Pediatrix Medical Group, Inc. (MD) Income Statement
MD 2025 at a glance
Fiscal year ended December 31, 2025 · U.S. dollarsMD revenue and net income
Where MD's revenue goes
2025Each bar shows an amount and its share of revenue. MD kept 8.6% of revenue as net income.
MD profit margins
MD growth rates
to 2025| 1 year | 3 years | 5 years | 10 years | |
|---|---|---|---|---|
| Revenue | −4.9% | −1.0% | +2.0% | −3.7% |
| Gross profit | +3.9% | +0.3% | +1.0% | −6.5% |
| Operating income | — | +10.2% | +18.7% | −8.4% |
| Net income | — | +35.6% | — | −6.9% |
| EPS (diluted) | +36.2% | +6.7% | +10.0% | −6.2% |
1-year change and average annual growth (CAGR) over 3, 5 and 10 fiscal years. "—" when a starting value was zero or negative.
MD quarterly EPS vs estimates
Pediatrix Medical beat the analyst EPS estimate in 7 of the last 8 quarters. Next report: November 2, 2026 (estimate $0.59).
MD income statement
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.91B | $2.01B | $1.99B | $1.97B | $1.91B | $1.73B | $1.78B | $3.65B | $3.46B | $3.18B |
| Cost of revenue | $1.44B | $1.56B | $1.57B | $1.50B | $1.40B | $1.28B | $1.28B | $2.66B | $2.46B | $2.15B |
| Gross profit | $471.9M | $454.3M | $421.6M | $467.0M | $513.2M | $449.3M | $503.1M | $989.5M | $1.00B | $1.03B |
| Research & development | — | — | — | — | — | — | — | $0 | $0 | $0 |
| Sales, general & admin | $240.8M | $238.4M | $227.5M | $231.4M | $263.4M | $248.9M | $244.5M | $432.4M | $417.1M | $372.6M |
| Total operating expenses | $240.8M | $523.1M | $414.2M | $294.3M | $310.3M | $351.2M | $331.3M | $543.7M | $520.0M | $461.8M |
| Operating income | $231.1M | −$68.7M | $7.3M | $172.7M | $202.9M | $98.1M | $171.8M | $445.8M | $480.1M | $571.7M |
| Interest income | $13.3M | $32.6M | $35.7M | $34.3M | $53.2M | $91.0M | $105.9M | $76.8M | $69.2M | $57.9M |
| Interest expense | $36.0M | $40.7M | $42.1M | $39.7M | $68.7M | $110.5M | $118.9M | $92.9M | $74.6M | $63.1M |
| Income before taxes | $216.4M | −$101.3M | −$48.4M | $81.4M | $135.2M | $7.1M | $58.8M | $368.8M | $410.4M | $513.8M |
| Income taxes | $51.0M | −$2.3M | $12.0M | $18.8M | $27.2M | $16.7M | $16.6M | $100.2M | $90.0M | $189.2M |
| Net income | $165.4M | −$99.1M | −$60.4M | $66.3M | $131.0M | −$796.5M | −$1.50B | $268.6M | $320.4M | $324.9M |
| EBITDA | $274.2M | −$28.4M | $29.9M | $156.7M | $236.1M | $146.1M | $203.6M | $468.2M | $587.9M | $661.0M |
| EPS (diluted) | $2.03 | $1.49 | $1.26 | $1.67 | $1.63 | $1.26 | $3.42 | $3.82 | $3.34 | $3.99 |
| Gross margin | 24.7% | 22.6% | 21.1% | 23.7% | 26.9% | 25.9% | 28.3% | 27.1% | 28.9% | 32.5% |
| Operating margin | 12.1% | −3.4% | 0.4% | 8.8% | 10.6% | 5.7% | 9.7% | 12.2% | 13.9% | 18.0% |
| Net margin | 8.6% | −4.9% | −3.0% | 3.4% | 6.9% | −45.9% | −84.2% | 7.4% | 9.3% | 10.2% |
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 | Jun '24 | Mar '24 | Dec '23 | Sep '23 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $487.8M | $476.2M | $493.8M | $492.9M | $468.8M | $458.4M | $502.4M | $511.2M | $504.3M | $495.1M | $496.4M | $506.6M |
| Cost of revenue | $355.3M | $363.2M | $373.4M | $352.5M | $344.1M | $355.7M | $373.8M | $394.3M | $390.2M | $400.2M | $395.3M | $399.7M |
| Gross profit | $132.5M | $113.0M | $120.4M | $140.3M | $124.7M | $102.6M | $128.5M | $116.8M | $114.1M | $94.9M | $101.2M | $106.9M |
| Sales, general & admin | $61.3M | $60.3M | $65.7M | $60.8M | $55.7M | $58.6M | $63.6M | $58.1M | $56.6M | $60.2M | $53.1M | $57.4M |
| Total operating expenses | $75.5M | $66.4M | $65.7M | $72.3M | $64.9M | $70.5M | $89.2M | $83.0M | $271.8M | $79.0M | $212.7M | $66.6M |
| Operating income | $56.9M | $46.6M | $54.7M | $68.1M | $59.9M | $32.1M | $39.3M | $33.8M | −$157.7M | $15.9M | −$111.5M | $40.3M |
| Interest income | — | — | $3.2M | $1.2M | $4.9M | $4.0M | $6.0M | $8.6M | — | — | — | $9.4M |
| Interest expense | $8.2M | $8.3M | $8.7M | $3.1M | $9.1M | $9.2M | $9.7M | $10.1M | $10.3M | $10.6M | $10.1M | $10.4M |
| Income before taxes | $54.0M | $38.8M | $45.6M | $87.8M | $55.0M | $28.1M | $33.3M | $25.2M | −$167.7M | $7.8M | −$138.8M | $30.8M |
| Income taxes | $14.2M | $9.3M | $11.9M | $16.1M | $15.7M | $7.4M | $2.8M | $5.8M | −$14.7M | $3.8M | −$14.6M | $9.4M |
| Net income | $39.8M | $29.6M | $33.7M | $71.7M | $39.3M | $20.7M | $30.5M | $19.4M | −$153.0M | $4.0M | −$124.3M | $21.4M |
| EBITDA | $57.5M | $53.2M | $60.0M | $96.4M | $69.4M | $42.6M | $49.9M | $41.6M | −$148.6M | $28.7M | −$119.7M | $50.4M |
| EPS (diluted) | $0.58 | $0.44 | $0.50 | $0.67 | $0.53 | $0.33 | $0.51 | $0.44 | $0.34 | $0.20 | $0.32 | $0.32 |
| Gross margin | 27.2% | 23.7% | 24.4% | 28.5% | 26.6% | 22.4% | 25.6% | 22.9% | 22.6% | 19.2% | 20.4% | 21.1% |
| Operating margin | 11.7% | 9.8% | 11.1% | 13.8% | 12.8% | 7.0% | 7.8% | 6.6% | −31.3% | 3.2% | −22.5% | 7.9% |
| Net margin | 8.2% | 6.2% | 6.8% | 14.5% | 8.4% | 4.5% | 6.1% | 3.8% | −30.3% | 0.8% | −25.0% | 4.2% |
Quarterly columns are labeled by the month the quarter ended. Figures in U.S. dollars as reported in MD's financial statements (latest annual report filed February 19, 2026); data from EODHD. Sales, general & administrative expenses include sales and marketing.
MD financial results
In fiscal year 2025 (ended December 31, 2025), Pediatrix Medical reported revenue of $1.9 billion, down 4.9% from the year before. It had net income of $165.4 million, a net profit margin of 8.6%. Diluted earnings per share came to $2.03. Over five years revenue grew at an average rate of 2.0% a year.
See the MD stock overview for the latest quote and news, or the MD chart for price history and technical indicators.
MD income statement FAQ
What is Pediatrix Medical's annual revenue?
Pediatrix Medical reported total revenue of $1.9 billion for fiscal year 2025, which ended on December 31, 2025. That was down 4.9% from $2.0 billion the previous year.
Is Pediatrix Medical profitable?
Yes. Pediatrix Medical reported net income of $165.4 million in fiscal 2025, a net profit margin of 8.6%; its operating margin was 12.1%.
What is Pediatrix Medical's gross margin?
Pediatrix Medical's gross margin was 24.7% in fiscal 2025: for every $100 of revenue, Pediatrix Medical kept $25 after the direct cost of its products and services.
How fast is Pediatrix Medical growing?
Revenue grew 2.0% a year on average over the last five fiscal years, from $1.7 billion to $1.9 billion.
What are Pediatrix Medical's earnings per share?
Pediatrix Medical earned $2.03 per diluted share in fiscal 2025, compared with $1.49 a year earlier.
When will Pediatrix Medical report its next earnings?
Pediatrix Medical is expected to report results for the quarter ending September 30, 2026 on November 2, 2026 before the market opens.
When does Pediatrix Medical's fiscal year end?
Pediatrix Medical's fiscal year ends in December. The latest annual report covers the year ended December 31, 2025 and was filed on February 19, 2026.